Indefinite Delivery Contract SPE2DR25D9755

The Defense Logistics Agency (DLA) has awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 under the SPE2DB program. This IDC enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

The IDC was awarded as a result of a planned solicitation by the DLA Troop Support Medical Supply Chain to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency, United States Coast Guard, and US Naval Fleet. The acquisition is expected to have a total estimated value of $30.3 billion, with multiple primary supplier awards for separate regions and at least three different contractors selected. The contract will be a firm-fixed price, requirements-type contract with a 30-month base period and three 30-month option periods, awarded on a lowest price technically acceptable basis.